N-methyl-D-aspartate receptor glycine modulatory site (NMDA receptor GMS)

The N-methyl-D-aspartate receptor glycine modulatory site (GMS) is a distinct co-agonist binding pocket located primarily on the GluN1 subunit of the NMDA receptor. Activation of NMDA receptors requires both glutamate binding to the GluN2 subunit and glycine or D-serine binding to the glycine modulatory site on GluN1. This dual-ligand requirement makes the GMS a critical regulator of NMDA receptor function, influencing synaptic transmission, neuroplasticity, and cognitive processes in the CNS. Several drugs and endogenous ligands act directly or indirectly on this site to modulate NMDA receptor activity, thereby impacting diseases such as schizophrenia, depression, Alzheimer's disease, epilepsy, and other CNS disorders. The site is strychnine-insensitive, distinguishing it from classical glycine receptors, and is a target for pharmacological interventions aiming either to enhance or inhibit NMDA receptor-mediated signaling.

Other names

Glycine modulatory siteGlycine-B siteStrychnine-insensitive glycine site

Agonist binding: Enhances NMDA receptor activation (e.g., glycine, D-serine) Antagonist binding: Inhibits NMDA receptor activation by competitive or noncompetitive binding to the glycine modulatory site Partial agonist/antagonist effects: D-cycloserine modulates receptor activity depending on concentration and context